Cannapharmarx Inc (CPMD)
0.01
0.00 (0.00%)
USD |
OTCM |
May 17, 16:00
Cannapharmarx Shareholders Equity (Quarterly): -20.63M for Sept. 30, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
September 30, 2023 | -20.63M |
June 30, 2023 | -20.14M |
March 31, 2023 | -18.21M |
December 31, 2022 | -17.34M |
September 30, 2022 | -14.98M |
June 30, 2022 | -14.70M |
March 31, 2022 | -14.29M |
December 31, 2021 | -12.93M |
September 30, 2021 | -6.288M |
June 30, 2021 | -6.394M |
March 31, 2021 | -6.850M |
December 31, 2020 | -8.802M |
September 30, 2020 | 1.461M |
June 30, 2020 | 2.726M |
March 31, 2020 | 1.269M |
December 31, 2019 | 4.854M |
September 30, 2019 | 12.61M |
June 30, 2019 | 11.73M |
March 31, 2019 | 12.28M |
December 31, 2018 | -0.2863M |
September 30, 2018 | -1.165M |
June 30, 2018 | -0.9748M |
March 31, 2018 | -0.9643M |
December 31, 2017 | -0.9643M |
September 30, 2017 | -0.9593M |
Date | Value |
---|---|
June 30, 2017 | -0.9593M |
March 31, 2017 | -0.9593M |
December 31, 2016 | -0.9577M |
September 30, 2016 | -0.9214M |
June 30, 2016 | -0.8919M |
March 31, 2016 | -0.8285M |
December 31, 2015 | -0.6845M |
September 30, 2015 | -0.2048M |
June 30, 2015 | 0.406M |
March 31, 2015 | -0.5516M |
December 31, 2014 | -0.2882M |
September 30, 2014 | 2.452M |
June 30, 2014 | 1.979M |
March 31, 2014 | -0.3177M |
December 31, 2013 | -0.292M |
September 30, 2013 | -0.2698M |
June 30, 2013 | -0.2446M |
March 31, 2013 | -0.2205M |
December 31, 2012 | -0.1976M |
September 30, 2012 | -0.1768M |
June 30, 2012 | -0.1535M |
March 31, 2012 | -0.1355M |
December 31, 2011 | -0.0996M |
September 30, 2011 | -0.0777M |
June 30, 2011 | -0.0511M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-20.63M
Minimum
Sep 2023
12.61M
Maximum
Sep 2019
-7.051M
Average
-7.826M
Median
Shareholders Equity (Quarterly) Benchmarks
Acasti Pharma Inc | 64.68M |
Aurinia Pharmaceuticals Inc | 377.95M |
Edesa Biotech Inc | 4.324M |
Lexaria Bioscience Corp | 6.521M |
Xenon Pharmaceuticals Inc | 887.70M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 5.156M |
Total Liabilities (Quarterly) | 25.79M |